We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

OCT 22 2020

Federal Circuit To Decide Limits On Functional Claiming Of Isolated Monoclonal Antibodies - Biosimilar Development

Drew Hillier, associate in the firm's Litigation section, co-authored an article for Biosimilar Development, “Federal Circuit To Decide Limits On Functional Claiming Of Isolated Monoclonal Antibodies.”